Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms.

PubWeight™: 3.41‹?› | Rank: Top 1%

🔗 View Article (PMC 28460)

Published in BMJ on February 21, 1998

Authors

H L Crimlisk1, K Bhatia, H Cope, A David, C D Marsden, M A Ron

Author Affiliations

1: Institute of Neurology, London.

Articles citing this

Systematic review of misdiagnosis of conversion symptoms and "hysteria". BMJ (2005) 4.25

The 12 year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry (2003) 1.78

Assessment and management of medically unexplained symptoms. BMJ (2008) 1.59

A Bayesian account of 'hysteria'. Brain (2012) 1.50

The outcome of neurology outpatients with medically unexplained symptoms: a prospective cohort study. J Neurol Neurosurg Psychiatry (2003) 1.48

Medically unexplained neurological symptoms. BMJ (1998) 1.47

Long-term outcome and prognosis of dissociative disorder with onset in childhood or adolescence. Child Adolesc Psychiatry Ment Health (2008) 1.04

Functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry (2002) 1.02

Psychogenic tremor and related disorders. J Neurol (2007) 1.00

Functional symptoms in neurology: management. J Neurol Neurosurg Psychiatry (2005) 0.96

Diagnostic agreement in patients with psychogenic movement disorders. Mov Disord (2012) 0.95

Psychogenic movement disorders. Continuum (Minneap Minn) (2013) 0.95

Streamlined classification of psychopathological hand disorders: A literature review. Hand (N Y) (2007) 0.91

Progress in understanding conversion disorder. Neuropsychiatr Dis Treat (2005) 0.90

Prognosis of symptoms that are medically unexplained. Every neurology service should have access to specialist liaison psychiatry. BMJ (1998) 0.88

Functional symptoms in neurology: questions and answers. J Neurol Neurosurg Psychiatry (2005) 0.87

Treatment of functional (psychogenic) movement disorders. Neurotherapeutics (2014) 0.87

Dissociative paraplegia after epidural anesthesia: a case report. J Med Case Rep (2013) 0.86

Psychogenic movement disorders and motor conversion: a roadmap for collaboration between neurology and psychiatry. Psychosomatics (2011) 0.85

Which neurological diseases are most likely to be associated with "symptoms unexplained by organic disease". J Neurol (2011) 0.84

Clinical Manifestations and Management of Conversion Disorders. Curr Treat Options Neurol (2002) 0.82

New approaches to conversion hysteria. BMJ (2000) 0.81

Conversion disorder: towards a neurobiological understanding. Neuropsychiatr Dis Treat (2006) 0.80

Functional illness in primary care: dysfunction versus disease. BMC Fam Pract (2008) 0.80

Psychogenic movement disorders. Neurol Clin (2009) 0.79

Somatization Disorder. Curr Treat Options Neurol (2001) 0.77

Movement disorders: Psychogenic movement disorders: what do neurologists do? Nat Rev Neurol (2009) 0.77

The choking woman. London J Prim Care (Abingdon) (2015) 0.75

Prognosis of symptoms that are medically unexplained. Follow up study needs to be continued for longer. BMJ (1998) 0.75

Medically unexplained illness and the diagnosis of hysterical conversion reaction (HCR) in women's medicine wards of Bangladeshi hospitals: a record review and qualitative study. BMC Womens Health (2012) 0.75

Prognosis of symptoms that are medically unexplained. Clinical guidelines are needed. BMJ (1998) 0.75

Hysterical paralysis after spinal surgery. Rheumatol Int (2011) 0.75

Articles cited by this

A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry (1978) 12.65

DIAGNOSIS OF "HYSTERIA". Br Med J (1965) 7.20

'Hysteria', 'functional' or 'psychogenic'? A survey of British neurologists' preferences. J R Soc Med (1991) 2.39

A follow-up of patients diagnosed as suffering from "hysteria". J Psychosom Res (1965) 2.38

Paroxysmal dyskinesias: clinical features and classification. Ann Neurol (1995) 2.21

Hysteria--a neurologist's view. Psychol Med (1986) 2.12

Prognosis and differential diagnosis of conversion reactions. Dis Nerv Syst (1962) 1.91

Psychogenic movement disorders: frequency, clinical profile, and characteristics. J Neurol Neurosurg Psychiatry (1995) 1.50

Hysterical neurosis, conversion type: clinical and epidemiological considerations. Acta Psychiatr Scand (1976) 1.43

Ten-year prognosis of conversion disorder. Br J Psychiatry (1996) 1.38

Outcome in conversion disorder: a follow up study. J Neurol Neurosurg Psychiatry (1995) 1.34

Psychogenic disorders in neurology: frequency and clinical spectrum. Acta Neurol Scand (1990) 1.33

The frequency and identification of false positive conversion reactions. J Nerv Ment Dis (1979) 1.20

An investigation of hysteria using the Illness Behaviour Questionnaire. Br J Psychiatry (1985) 1.13

Hysterical paraplegia. J Neurol Neurosurg Psychiatry (1987) 1.12

Diagnosis of conversion reactions. Predictive value of psychiatric criteria. JAMA (1966) 1.09

Somatization in patients newly admitted to a neurological department. Acta Psychiatr Scand (1994) 0.98

Hysteria. J Psychosom Res (1980) 0.97

Articles by these authors

(truncated to the top 100)

Corticocortical inhibition in human motor cortex. J Physiol (1993) 8.92

A report--chronic fatigue syndrome: guidelines for research. J R Soc Med (1991) 7.70

Health of UK servicemen who served in Persian Gulf War. Lancet (1999) 6.81

Mitochondrial complex I deficiency in Parkinson's disease. Lancet (1989) 5.72

Electric and magnetic stimulation of human motor cortex: surface EMG and single motor unit responses. J Physiol (1989) 5.69

Postgraduate training for overseas doctors in Britain. BMJ (1994) 5.54

Geographic variation in human mitochondrial DNA from Papua New Guinea. Genetics (1990) 5.44

Servo action in the human thumb. J Physiol (1976) 4.93

Interhemispheric inhibition of the human motor cortex. J Physiol (1992) 4.77

A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature (2010) 4.52

Servo action in human voluntary movement. Nature (1972) 4.33

Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem (1990) 4.03

Are British psychiatrists racist? Br J Psychiatry (1990) 3.82

Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain (1995) 3.71

Painful legs and moving toes. Brain (1971) 3.63

Schizophrenia and city life. Lancet (1992) 3.60

Is there a Gulf War syndrome? Lancet (1999) 3.58

Validity and reliability of a rating scale for the primary torsion dystonias. Neurology (1985) 3.56

The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain (1994) 3.54

A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol (2000) 3.44

Writers' cramp-a focal dystonia. Brain (1982) 3.43

Outcome of investigation of patients with presenile dementia. Br Med J (1972) 3.39

Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science (1990) 3.31

Stretch reflex and servo action in a variety of human muscles. J Physiol (1976) 3.29

Scope of a technique for electrical stimulation of human brain, spinal cord, and muscle. Lancet (1982) 3.26

The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture. Neurology (1982) 3.26

Corticobasal degeneration. Brain (1989) 3.20

Stimulation of the human motor cortex through the scalp. Exp Physiol (1991) 3.16

Statistical methods of estimation and inference for functional MR image analysis. Magn Reson Med (1996) 3.13

Compliance therapy in psychotic patients: randomised controlled trial. BMJ (1996) 3.09

Premorbid adjustment and personality in people with schizophrenia. Br J Psychiatry (1998) 3.00

Peripheral beta-adrenergic receptors concerned with tremor. Clin Sci (1967) 2.97

The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med (1980) 2.81

Motor cortex stimulation in intact man. 2. Multiple descending volleys. Brain (1987) 2.77

Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. Ann Neurol (1995) 2.76

Classification of dystonia. Adv Neurol (1998) 2.75

Botulinum toxin in spasmodic torticollis. J Neurol Neurosurg Psychiatry (1988) 2.74

Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia? J Neurol Neurosurg Psychiatry (1976) 2.72

Predictors of chronic "postviral" fatigue. Lancet (1994) 2.72

Overuse of the indwelling urinary tract catheter in hospitalized medical patients. Arch Intern Med (1995) 2.69

High frequencies of alpha-thalassaemia are the result of natural selection by malaria. Nature (1986) 2.68

Chronic fatigue, ME, and ICD-10. Lancet (1993) 2.67

Human walking and higher-level gait disorders, particularly in the elderly. Neurology (1993) 2.65

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol (1994) 2.65

Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain (1992) 2.64

Manual motor performance in a deafferented man. Brain (1982) 2.63

The anatomical basis of symptomatic hemidystonia. Brain (1985) 2.60

Is the human stretch reflex cortical rather than spinal? Lancet (1973) 2.58

Distribution of ADH2 and ALDH2 genotypes in different populations. Hum Genet (1992) 2.55

"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet (1976) 2.54

Movement disorders in multiple sclerosis. Mov Disord (1995) 2.53

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain (1991) 2.52

The pathophysiology of primary dystonia. Brain (1998) 2.51

Pathophysiology of blepharospasm and oromandibular dystonia. Brain (1985) 2.50

A method of monitoring function in corticospinal pathways during scoliosis surgery with a note on motor conduction velocities. J Neurol Neurosurg Psychiatry (1986) 2.50

Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry (1988) 2.46

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol (1990) 2.45

Changes in the response to magnetic and electrical stimulation of the motor cortex following muscle stretch in man. J Physiol (1991) 2.44

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem (1989) 2.44

Neurophysiologic analysis of neuromuscular symptoms in UK Gulf War veterans: a controlled study. Neurology (2002) 2.42

Attitudes of families to some aspects of Huntington's chorea. Psychol Med (1979) 2.40

A study of hereditary essential tremor. Brain (1994) 2.37

Focal dystonia of the jaw and the differential diagnosis of unilateral jaw and masticatory spasm. J Neurol Neurosurg Psychiatry (1986) 2.37

'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain (1988) 2.36

Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology (1992) 2.36

Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy') Br J Psychiatry (1994) 2.35

Management of chronic (post-viral) fatigue syndrome. J R Coll Gen Pract (1989) 2.31

Disturbance of sequential movements in patients with Parkinson's disease. Brain (1987) 2.30

Abnormalities in central motor pathway conduction in multiple sclerosis. Lancet (1984) 2.30

Postural electromyographic responses in the arm and leg following galvanic vestibular stimulation in man. Exp Brain Res (1993) 2.30

Isolated single motor units in human muscle and their rate of discharge during maximal voluntary effort. J Physiol (1971) 2.28

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem (1989) 2.26

Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam. Brain (1977) 2.23

Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry (1998) 2.22

The problem of adult-onset idiopathic torsion dystonia and other isolated dyskinesias in adult life (including blepharospasm, oromandibular dystonia, dystonic writer's cramp, and torticollis, or axial dystonia). Adv Neurol (1976) 2.19

Delay in the execution of voluntary movement by electrical or magnetic brain stimulation in intact man. Evidence for the storage of motor programs in the brain. Brain (1989) 2.19

The sensory mechanism of servo action in human muscle. J Physiol (1977) 2.18

Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics. J Neurol Neurosurg Psychiatry (1976) 2.18

Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet (1997) 2.16

Randomised controlled trial of compliance therapy. 18-month follow-up. Br J Psychiatry (1998) 2.15

Thromboembolic phenomena after ovarian stimulation with human gonadotrophins. Lancet (1965) 2.15

Rate of sequence divergence estimated from restriction maps of mitochondrial DNAs from Papua New Guinea. Cold Spring Harb Symp Quant Biol (1986) 2.13

Hysteria--a neurologist's view. Psychol Med (1986) 2.12

Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem (1997) 2.10

Corticobasal degeneration. A clinical study of 36 cases. Brain (1994) 2.10

Non-paternity and genetic counselling. Lancet (1992) 2.09

'Subcortical dementia': the neuropsychological evidence. Neuroscience (1988) 2.08

Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder. Brain (1995) 2.06

Ballistic flexion movements of the human thumb. J Physiol (1979) 2.06

Disruption of spatial organization and interjoint coordination in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy. Mov Disord (2000) 2.06

Diagnostic accuracy in presenile dementia. Br J Psychiatry (1979) 2.06

Reciprocal inhibition between the muscles of the human forearm. J Physiol (1984) 2.05

Relationship between plasma propranolol concentration and relief of essential tremor. J Neurol Neurosurg Psychiatry (1979) 2.04

Explicit and implicit neural mechanisms for processing of social information from facial expressions: a functional magnetic resonance imaging study. Hum Brain Mapp (2000) 2.04

Teaching tape for the motor section of the unified Parkinson's disease rating scale. Mov Disord (1995) 2.03

Reflection impulsivity and response inhibition in first-episode psychosis: relationship to cannabis use. Psychol Med (2013) 2.02

Modulation of motor cortical excitability by electrical stimulation over the cerebellum in man. J Physiol (1991) 2.01

The anatomy of conscious vision: an fMRI study of visual hallucinations. Nat Neurosci (1998) 2.01

Cannot ventilate, difficult to intubate. Eur J Anaesthesiol (2006) 2.01

Role of vaccinations as risk factors for ill health in veterans of the Gulf war: cross sectional study. BMJ (2000) 1.98